Parmacek M S, Ip H S, Jung F, Shen T, Martin J F, Vora A J, Olson E N, Leiden J M
Department of Medicine, University of Chicago, Illinois 60637.
Mol Cell Biol. 1994 Mar;14(3):1870-85. doi: 10.1128/mcb.14.3.1870-1885.1994.
The slow/cardiac troponin C (cTnC) gene is expressed in three distinct striated muscle lineages: cardiac myocytes, embryonic fast skeletal myotubes, and adult slow skeletal myocytes. We have reported previously that cTnC gene expression in cardiac muscle is regulated by a cardiac-specific promoter/enhancer located in the 5' flanking region of the gene (bp -124 to +1). In this report, we demonstrate that the cTnC gene contains a second distinct and independent transcriptional enhancer which is located in the first intron. This second enhancer is skeletal myotube specific and is developmentally up-regulated during the differentiation of myoblasts to myotubes. This enhancer contains three functionally important nuclear protein binding sites: a CACCC box, a MEF-2 binding site, and a previously undescribed nuclear protein binding site, designated MEF-3, which is also present in a large number of skeletal muscle-specific transcriptional enhancers. Unlike most skeletal muscle-specific transcriptional regulatory elements, the cTnC enhancer does not contain a consensus binding site (CANNTG) for the basic helix-loop-helix (bHLH) family of transcription factors and does not directly bind MyoD-E12 protein complexes. Despite these findings, the cTnC enhancer can be transactivated by overexpression of the myogenic bHLH proteins, MyoD and myogenin, in C3H10T1/2 (10T1/2) cells. Electrophoretic mobility shift assays demonstrated changes in the patterns of MEF-2, CACCC, and MEF-3 DNA binding activities following the conversion of 10T1/2 cells into myoblasts and myotubes by stable transfection with a MyoD expression vector. In particular, MEF-2 binding activity was up-regulated in 10T1/2 cells stably transfected with a MyoD expression vector only after these cells fused and differentiated into skeletal myotubes. Taken together, these results demonstrated that distinct lineage-specific transcriptional regulatory elements control the expression of a single myofibrillar protein gene in fast skeletal and cardiac muscle. In addition, they show that bHLH transcription factors can indirectly transactivate the expression of some muscle-specific genes.
慢肌/心肌肌钙蛋白C(cTnC)基因在三种不同的横纹肌谱系中表达:心肌细胞、胚胎快肌骨骼肌肌管和成体慢肌骨骼肌细胞。我们之前报道过,心肌中cTnC基因的表达受位于该基因5'侧翼区域(碱基对-124至+1)的心脏特异性启动子/增强子调控。在本报告中,我们证明cTnC基因包含第二个不同且独立的转录增强子,它位于第一个内含子中。这个第二个增强子是骨骼肌肌管特异性的,并且在成肌细胞向肌管分化过程中在发育上上调。这个增强子包含三个功能重要的核蛋白结合位点:一个CACCC框、一个MEF-2结合位点和一个先前未描述的核蛋白结合位点,命名为MEF-3,它也存在于大量骨骼肌特异性转录增强子中。与大多数骨骼肌特异性转录调控元件不同,cTnC增强子不包含转录因子基本螺旋-环-螺旋(bHLH)家族的共有结合位点(CANNTG),也不直接结合MyoD-E12蛋白复合物。尽管有这些发现,但cTnC增强子可通过在C3H10T1/2(10T1/2)细胞中过表达成肌bHLH蛋白MyoD和肌细胞生成素而被反式激活。电泳迁移率变动分析表明,在用MyoD表达载体稳定转染使10T1/2细胞转变为成肌细胞和肌管后,MEF-2、CACCC和MEF-3 DNA结合活性的模式发生了变化。特别是,只有在这些细胞融合并分化为骨骼肌肌管后,用MyoD表达载体稳定转染的10T1/2细胞中MEF-2结合活性才会上调。综上所述,这些结果表明,不同的谱系特异性转录调控元件控制着快肌骨骼肌和心肌中单个肌原纤维蛋白基因的表达。此外,它们还表明bHLH转录因子可间接反式激活某些肌肉特异性基因的表达。